Zepbound helps users lose more weight than Wegovy, new trial reveals

Q: How long will it take to read this news story?

The story "Zepbound helps users lose more weight than Wegovy, new trial reveals" has 532 words across 27 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Zepbound helps users lose more weight than Wegovy, new trial reveals" was covered 11 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 293 news stories per day. It's most recent story was published 4 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #28609436</li><li>URL: https://inconstantly.beamstart.com/news/zepbound-helps-users-lose-more-17470527561472</li></ul>

Business Standard Logo Business Standard 11h ago

Zepbound helps users lose more weight than Wegovy, new trial reveals - Business Standard

Quick Summary:

Wegovy users were slightly more likely to discontinue the treatment due to nausea, vomiting, or other gastrointestinal issues.

Wegovy is expected to be launched in India soon, but its price is still being discussed, with estimates ranging from around ₹8,000 to ₹14,000 per month.

The report said researchers highlighted that this kind of sustained weight loss is clinically meaningful and can reduce the risk of multiple chronic diseases.